Trials / Completed
CompletedNCT01986660
Open-Label, Maximum-Dose Pharmacokinetic Study of 7.5% Ibuprofen Cream (SST-0225) in Healthy Adults
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Strategic Science & Technologies, LLC · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate how Ibuprofen Cream (SST-0225) is absorbed and eliminated by the body under defined maximum dosing conditions and to evaluate the safety under these conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ibuprofen Cream (SST-0225) |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2013-10-01
- Completion
- 2013-10-01
- First posted
- 2013-11-18
- Last updated
- 2014-01-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01986660. Inclusion in this directory is not an endorsement.